Thoma Bravo invests in medication intelligence firm Bluesight
The investment will be used to back Bluesight's acquisition of Medacist, a drug diversion monitoring firm.
17 July 2023•1 min read
The investment will be used to back Bluesight's acquisition of Medacist, a drug diversion monitoring firm.
Strategic Value Partners agrees to back NewEdge Power in battery storage JV
44 minutes ago · 2 mins read
Oak Hill strikes deal to take majority stake in Wyyerd from Carlyle
55 minutes ago · 2 mins read
Polaris Growth Fund backs commercial real estate software firm ID Plans
1 hour ago · 1 min read
Third Space Partners buys live event drape and scenic provider Quest Events
1 hour ago · 2 mins read
RedBird Capital Partners and Sound Ventures form $1bn tech and media partnership
2 hours ago · 2 mins read
Housatonic Partners inks sale of Onrad to RadNet for $350m plus stock
3 hours ago · 2 mins read
InTandem Capital Partners completes growth investment in Atlas Health
3 hours ago · 2 mins read
